| Tretinoin | Approved Investigational Nutraceutical | OR7E47P | 26628 |
downregulated | Tretinoin results in decreased expression of OR7E47P mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | OR7E5P | 219445 |
downregulated | Tretinoin results in decreased expression of OR7E5P mRNA | 11q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OR7H2P | 403301 |
downregulated | Tretinoin results in decreased expression of OR7H2P mRNA | 5q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OR8B8 | 26493 |
downregulated | Tretinoin results in decreased expression of OR8B8 mRNA | 11q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ORC1 | 4998 |
downregulated | Tretinoin results in decreased expression of ORC1 mRNA | 1p32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ORC2 | 4999 |
downregulated | Tretinoin results in decreased expression of ORC2 mRNA | 2q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ORC5 | 5001 |
downregulated | Tretinoin results in decreased expression of ORC5 mRNA | 7q22.1-q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | OSBPL10 | 114884 |
upregulated | Tretinoin results in increased expression of OSBPL10 mRNA | 3p23 | |
| Tretinoin | Approved Investigational Nutraceutical | OSBPL5 | 114879 |
upregulated | Tretinoin results in increased expression of OSBPL5 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | OSBPL8 | 114882 |
downregulated | Tretinoin results in decreased expression of OSBPL8 mRNA | 12q14 | |
| Tretinoin | Approved Investigational Nutraceutical | OSMR | 9180 |
upregulated | Tretinoin results in increased expression of OSMR mRNA | 5p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OSTM1 | 28962 |
upregulated | Tretinoin results in increased expression of OSTM1 mRNA | 6q21 | |
| Tretinoin | Approved Investigational Nutraceutical | OTOR | 56914 |
downregulated | Tretinoin results in decreased expression of OTOR mRNA | 20p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OTUD1 | 220213 |
upregulated | Tretinoin results in increased expression of OTUD1 mRNA | 10p12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | OTUD5 | 55593 |
upregulated | Tretinoin results in increased expression of OTUD5 mRNA | Xp11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | OTX2 | 5015 |
downregulated | Tretinoin results in decreased expression of OTX2 mRNA | 14q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | OXCT1 | 5019 |
downregulated | Tretinoin results in decreased expression of OXCT1 mRNA | 5p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OXCT2 | 64064 |
downregulated | Tretinoin results in decreased expression of OXCT2 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | OXGR1 | 27199 |
downregulated | Tretinoin results in decreased expression of OXGR1 mRNA | 13q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OXNAD1 | 92106 |
downregulated | Tretinoin results in decreased expression of OXNAD1 mRNA | 3p25.1-p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | OXR1 | 55074 |
upregulated | Tretinoin results in increased expression of OXR1 mRNA | 8q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OXTR | 5021 |
upregulated | Tretinoin results in increased expression of OXTR mRNA | 3p25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | P2RX5 | 5026 |
downregulated | Tretinoin results in decreased expression of P2RX5 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | P2RY14 | 9934 |
upregulated | Tretinoin results in increased expression of P2RY14 mRNA | 3q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | P2RY2 | 5029 |
upregulated | Tretinoin results in increased expression of P2RY2 mRNA | 11q13.4 | |